Navigation Links
Senesco's Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on 'Molecular Targets and Cancer Therapeutics'
Date:10/20/2008

NEW BRUNSWICK, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Alternext US: SNT) announced today that Catherine Taylor, one of the Company's funded researchers, will be presenting her findings related to Senesco's preclinical multiple myeloma data at the 20th EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics." Ms. Taylor is a member of the Department of Biology at the University of Waterloo, Ontario, Canada. The conference will take place from October 21-24 in Geneva, Switzerland.

Senesco's President and CEO, Bruce Galton, Executive Vice President and CSO, Dr. John E. Thompson, and Vice President of R&D, Richard Dondero, are all co-authors of the study entitled "Therapeutic intervention in a murine model of multiple myeloma with PEI nanocomplexes bearing an eIF5A siRNA and eIF5AK50R pDNA resulted in a significant anti-tumoural response."

A copy of the poster will be available at http://www.senesco.com once the presentation has been made.

About Senesco Technologies, Inc.

Senesco Technologies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain diseases inflammatory and ischemic diseases. Senesco takes its name from the scientific term for the aging of plant cells: senescence. Delaying cell breakdown in plants extends freshness after harvesting, while increasing crop yields, plant size and resistance to environmental stress. The Company believes that its technology can be used to develop superior strains of crops without any modification other than delaying natural plant senescence. Senesco has par
'/>"/>

SOURCE Senesco Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Genmab Announces Encouraging Preclinical Data for ofatumumab
2. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
3. Preclinical Research on Coronary Stent with CeloNova BioSciences Polyzene(R)- F Nanocoating Receives Award at CIRSE 2007
4. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
5. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
6. Arpida Presents Preclinical Data on AR-2474 at ICAAC
7. ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
8. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
9. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
10. Preclinical Efficacy Data Demonstrate Ability of Tengions Neo-Bladder Augment to Restore Bladder Function
11. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...4-year veteran of the high-technology industry, ha...development and intellectual property management c...e. The company also plans to invest in promising .... , Monterey, CA (PRWEB) ...veteran of the high-technology industry, has forme...
(Date:11/30/2009)...wire/ -- Acuo Technologies, developers of high-per...igration tools and services, today announced contr... Vendor Neutral Archive (VNA), providing the found...f hospitals, clinics and affiliates. ,, The arc...DICOM Services Grid(TM) Software. The Acuo VNA ar...
(Date:11/30/2009)...wire/ -- Biopharmaceutical company Kiadis,Pharma a...nrolled in its,multinational registration clinical...w reduction in transplant related mortality (TRM) ...ransplantation with a mismatched,(haplo-identical)...logeneic,stem cell transplantation but without hav...
(Date:11/30/2009)...FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq...dministration (FDA) has granted orphan drug design...dine phosphate, for the rare autoimmune disease La...as previously received orphan drug designation in ... Medicinal Products for Human Use of the European ...
Breaking Biology Technology:Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4
...omated the steps for the processing, storage and c...he New York Blood Center,s National Cord Blood P...stem, developed by ThermoGenesis Corp . and distr...harvesting of the stem cell-rich cord blood into a...ml, and in a functionally closed and sterile syste...
...tors alone, you might conclude its a real-life ver... in the hit animated movie Cars. But just as Radia...e theres a more prosperous, real-life road ahead f...use without a healthy Milwaukee, most of Wisconsin...ics confirms what most observers suspected: Milwau...
... medical informatics technology, announced that it...tion manager at the community health organization ... March 2006 and, according to ThedaCare, it has be... Evercore system integrates all of the clinical ob...nd, and makes the images of those devices visible ...
Other Biology Technology:GE partners with New York blood center 2It's an economic fact: As Milwaukee goes, so goes Wisconsin 2It's an economic fact: As Milwaukee goes, so goes Wisconsin 3
(Date:11/30/2009)... A team of scientists from The Forsyth Institute, ...DC and the Wadsworth Center, have used state-of-th...ecture of Treponema pallidum, the bacterium which ...tructure of the bacteria can now be shown in three... the pathogen and reveals previously unknown featu...
(Date:11/30/2009)... HOUSTON (Nov. 30, 2009) Scientists and engineers...cine and energy will come together Dec. 7 with le...ing oil and pumping blood. , Much like moving oi...rough the body. Both systems need clean, well-fun...es or corrosion, to function efficiently. Both ind...
(Date:11/30/2009)... As global temperatures continue to rise scientist...rstanding how species respond and adapt. In a pape..., Dr Francisco Rodriguez-Trelles and Dr Miguel Rod...y global warming of approximately 0.6˚C has a...r challenge facing ecologists and evolutionary bio...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3How can scientists measure evolutionary responses to climate change? 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 1New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 3New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 4New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 5Engineers produce how to guide for controlling the structure of nanoparticles 14270 1Engineers produce how to guide for controlling the structure of nanoparticles 14270 2Surgery Best for Carpal Tunnel Syndrome 58324 1Surgery Best for Carpal Tunnel Syndrome 58324 2Surgery Best for Carpal Tunnel Syndrome 58324 3
... 2008) -- On Nov. 8 and 9, Morgan Stanley Children...niversity Medical Center will host an "Innovations...att New York, which will feature lectures by inter...al research, genetic findings and stem cell therap... about congenital and primary immunodeficiencies; ...
...tudy led by investigators from Massachusetts Gener...look at how interactions between genes underlie a ...ory. Functional imaging studies reveal how a comb...ted with reduced activity of important brain struc...controls. The report has been released online in ...
...th expert Daniel Hayes, Ph.D., of the New York Cit... that a form of vitamin D could be one of our body... of radiation. Writing in the International Journ...ol, the active form of vitamin D, may protect us f...fe protective agent before or after a low-level nu...
Other Biology News:Innovations in Pediatric Medicine International Conference brings together pediatrics experts 2Interaction between gene variants may alter brain function in schizophrenia 2Could vitamin D save us from radiation? 2
Rabbit Anti-3-Ethynylestradiol Polyclonal Antibody, Unconjugated from Abcam
Anti-Ku (p70 / p80) Ab-3 Monoclonal Antibody, Unconjugated from Lab Vision
SV40 Large T Antigen from Chimerx
Rabbit Anti-Rat 5-HIAA Polyclonal Antibody, Unconjugated from ImmunoStar, Inc.
Biology Products: